OR WAIT null SECS
July 19, 2016
The collaboration will focus on the investigational candidate JTX-2011 and up to four other early-stage programs in immune-oncology.
July 14, 2016
GE further ramps up its cellular and gene therapy offerings with its acquisition of Biosafe, a cell processing solutions company.
June 21, 2016
A research team associated with Dr. Carl June announces it has discovered a way to engineer a patient’s own immune cells to recognize cancer-specific glycoantigens on tumor cells.
June 10, 2016
Results of a Phase II clinical trial reveal that stem-cell transplantation treatment following complete immune system destruction increases the duration of long-term remission in patients with multiple sclerosis.
May 06, 2016
The Cell and Gene Therapy Catapult released a review of their third annual survey of GMP cell and gene therapy facilities in the United Kingdom.
April 18, 2016
The National Institute of Health will conduct an internal review of the National Cancer Institute’s cell manufacturing facilities, which will affect multiple Kite projects.
March 02, 2016
The pharma company revealed in a fourth quarter call that it will improve its cell-culture capabilities by focusing on the use of naïve, highly proliferative cells to manufacture its CAR-T drug candidate.
January 06, 2016
The Cell Therapy Catapult, University of Birmingham, and Cancer Research Technology collaborate on CAR-T cell immuno-oncology therapy development.
December 05, 2015
TxCell signs strategic agreement with MaSTherCell for European manufacturing of its cell therapy products.
November 30, 2015
A study backed by the Centre of Regenerative Medicine found that laminins are crucial cell components that could help aid the commercial production of stem cell therapies.